Literature DB >> 2874713

Chemotherapy of East Coast fever. Treatment of infections induced by isolates of Theileria parva with halofuginone.

T T Dolan.   

Abstract

Cattle were infected with three isolates of Theileria parva and treated with halofuginone lactate during acute clinical disease. The health, weight gain and carrier state of the cattle were monitored for 15 months. Limited treatment rapidly reduced fever and parasitosis but parasite recrudescences occurred and 12 out of 21 treated cattle died. Persistent carrier states were identified with two T. p. parva isolate infections and a transient carrier state with T. p. lawrencei. Three cattle which died from a chronic wasting syndrome during the follow-up period showed exhaustion of lymph nodes but no Theileria macroschizonts were detected in any tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874713

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Elimination of Theileria buffeli infections from cattle by concurrent treatment with buparvaquone and primaquine phosphate.

Authors:  N P Stewart; A J de Vos; N McHardy; N F Standfast
Journal:  Trop Anim Health Prod       Date:  1990-05       Impact factor: 1.559

2.  Elimination of Theileria buffeli infections from cattle by concurrent treatment with primaquine phosphate and halofuginone lactate.

Authors:  N P Stewart; A J de Vos; I Shiels
Journal:  Trop Anim Health Prod       Date:  1990-05       Impact factor: 1.559

Review 3.  Review of Australian species of Theileria, with special reference to Theileria buffeli of cattle.

Authors:  N P Stewart; G Uilenberg; A J de Vos
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

4.  Effects of halofuginone lactate on lymphocytes and MDBK cells infected with Theileria annulata and/or vesicular stomatitis virus (VSV): an in vitro study.

Authors:  H Mehlhorn; W Raether
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.